Latest News
Xponential Fitness officer: 'We look forward to working with our partners in Portugal'
By Karla Florez | Nov 7, 2022
Xponential Fitness, Inc. recently signed a master franchise agreement with Porto-based Mitrinha & Libelinha, Lda. in Portugal for its Club Pilates brand, according to a press release.
CurveBeam CEO on StraxCorp merger: 'CurveBeam AI will continue to lead innovation in weight bearing CT imaging'
By Karla Florez | Oct 28, 2022
Medical imaging companies CurveBeam, LLC and StraxCorp, Ltd. recently signed a merger agreement on Oct. 12, a press release reported.
GE Healthcare CEO on multi-year deal: 'We value our long standing relationship with SQM'
By Karla Florez | Oct 24, 2022
GE Healthcare’s Pharmaceutical Diagnostics recently entered a multi-year deal with Chilean mining company Sociedad Quimica y Minera de Chile S.A., a press release reported.
Saama names new executive for Europe, APAC, India to better ‘serve customers and patients’
By Karla Florez | Oct 7, 2022
Saama, based in California, has appointed Neelesh Sali as head of Europe and APAC operations, and managing director of India.
Body Vision Medical carries out ‘expansion into international markets’ with Business Asia Consultants partnership
By Karla Florez | Oct 7, 2022
Body Vision Medical recently entered a partnership with Business Asia Consultants as it pursues a global expansion.
Brand Institute president on 20-year anniversary: 'One of the most satisfying parts has been building long-term relationships with our clients'
By Karla Florez | Sep 27, 2022
Brand Institute, based in New York, recently celebrated the 20-year anniversary of its European launch, a press release reported.
Align Technology opens facility in Poland 'to stay closer to our doctor customers and to continue to deliver outstanding quality of service' in EMEA region
By Karla Florez | Sep 23, 2022
Align Technology, Inc. recently opened its first Europe, Middle East and Africa (EMEA) regional manufacturing facility in Wroclaw, Poland.
AssisTek CEO: 'The new Copenhagen office will assist our team in providing unrivaled support to clientele'
By Karla Florez | Sep 13, 2022
AssisTek recently opened two new offices, based in Copenhagen, Denmark and Charleston, South Carolina, to continue fulfilling the demands of both, local and international customers, a press release reported.
Raízen teams up with ASR Group to help ‘consumers become more aware of the ingredients in their food’
By Karla Florez | Sep 2, 2022
Brazilian raw sugar exporter Raízen recently entered partnership with sugar refiner and marketer ASR Group, based in Florida, to develop a fully traceable and non-GMO sugar supply chain, Dive Wire reported.
Haffar: 'This newest facility will create significant local job growth potential'
By Karla Florez | Aug 31, 2022
PCI Pharma Services has officially opened a new Clinical Services Center of Excellence in Bridgewater, Massachusetts, a press release reported. The establishment is the first of its kind in the New England region to target the growing global demands of biologics developers.
Tegra Medical CEO: 'Tegra Medical is committed to its operations in Costa Rica'
By Karla Florez | Aug 25, 2022
Tegra Medical has expanded its Costa Rica-based operations with a new manufacturing building, according to a press release.
EMA validates Menarini Group's marketing authorization application for review of elacestrant, new breast cancer treatment
By John Kelly | Aug 24, 2022
Elcin Barker Ergun is the chief executive officer of the Menarini Group, an Italian pharmaceutical company.
Alliance Pharma expands Bioanalytical Services in Australia ‘to provide services critical to this market’ and ‘support the progression of clinical development for clients’
By Karla Florez | Aug 20, 2022
Alliance Pharma confirmed plans to open a bioanalytical laboratory, in Brisbane, Australia to multiply the bioanalytical support in the region.
Guerra: 'We look forward to contributing our findings to the global endovascular community'
By Karla Florez | Jul 28, 2022
Cordis has begun enrolling members for its European-based Radiancy clinical study, according to a press release.
Subtle Medical chief product officer: 'We are excited to deepen our existing distributor partnership with Incepto'
By Karla Florez | Jul 19, 2022
Subtle Medical will now offer AI applications SubtleMR and SubtlePET on European radiology artificial intelligence solutions company, Incepto’s platform as part of a partnership expansion between the two companies, according to a press release.
Natreve recalls select limited U.S. batches: 'A whey-derived flavoring ingredient was inadvertently used in the blend'
By Karla Florez | Jul 6, 2022
Natreve, based in Canada, has recalled several batches of its Vegan Protein Powder French Vanilla Wafer Sundae flavor after finding trace amounts of undeclared milk following an external manufacturing production error, a press release reported.
Cigna completes transaction with Chubb to 'further focus our efforts to grow our global health portfolio'
By Karla Florez | Jul 5, 2022
Cigna Corporation confirmed the completion of $5.4 billion transaction with Chubb to grant access to its life, accident and supplemental benefits businesses in six markets across Asia Pacific, according to Cision PR Newswire.
Lamb: 'Expanding our biotherapeutics pipeline is a key strategic priority'
By Karla Florez | Jun 21, 2022
Exelixis, Inc. has entered an option and license agreement with BioInvent International AB to identify and develop novel antibodies for use in IO therapeutics, according to a press release.
Jordan: 'PCI will provide a critical function in the supply chain, by directly purchasing lenzilumab for further distribution in the UK'
By Karla Florez | Jun 17, 2022
Humanigen, Inc., based in New Jersey, recently partnered with PCI Pharma Services to offer importation, release and commercialization solutions in the UK for the humanized monoclonal antibody, lenzilumab, according to a press release.
AlgoTx CEO: 'We look forward to interacting closely with the FDA to bring relief to patients as quickly as possible'
By Karla Florez | Jun 14, 2022
The U.S. Food and Drug Administration (FDA) has granted a France-based brand, AlgoTx, with a Fast Track designation to further advance the development of chemotherapy-induced neuropathic pain treatment.